Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2014.
作者信息
da Silva Araújo Aderson, de Castro Lobo Clarisse Lopes, Covas Dimas Tadeu, Costa Fernando Ferreira, Medeiros Letícia, Cançado Rodolfo Delfini, Gualandro Sandra Fátima Menosi, Saad Sara Teresinha Olalla
机构信息
Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil.
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.
出版信息
Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):450-3. doi: 10.1016/j.bjhh.2014.09.009. Epub 2014 Oct 1.
Abstract
摘要
相似文献
1
Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2014.
Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):450-3. doi: 10.1016/j.bjhh.2014.09.009. Epub 2014 Oct 1.
2
Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.
Rev Bras Hematol Hemoter. 2016 Jan-Feb;38(1):58-74. doi: 10.1016/j.bjhh.2016.01.001. Epub 2016 Feb 5.
3
Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.
Hematol Transfus Cell Ther. 2018 Jan-Mar;40(1):50-74. doi: 10.1016/j.htct.2017.11.001. Epub 2018 Feb 17.
4
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.
Rev Bras Hematol Hemoter. 2013;35(3):201-17. doi: 10.5581/1516-8484.20130050.
5
Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.
Rev Bras Hematol Hemoter. 2013;35(6):417-27. doi: 10.5581/1516-8484.20130124.
6
Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013.
Rev Bras Hematol Hemoter. 2014;36(1):71-92. doi: 10.5581/1516-8484.20140018.
7
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):410-418. doi: 10.1016/j.htct.2022.06.003. Epub 2022 Jul 20.
8
Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.
Rev Bras Hematol Hemoter. 2013;35(5):358-65. doi: 10.5581/1516-8484.20130105.
9
Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016.
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):341-345. doi: 10.1016/j.bjhh.2016.09.003. Epub 2016 Sep 22.
10
Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):147-57. doi: 10.1016/j.bjhh.2016.04.001. Epub 2016 Apr 8.
本文引用的文献
1
Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
N Engl J Med. 2010 Sep 16;363(12):1146-55. doi: 10.1056/NEJMoa1005109.
2
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.
3
Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.
Adv Chronic Kidney Dis. 2009 Mar;16(2):117-30. doi: 10.1053/j.ackd.2008.12.010.
4
Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
J Formos Med Assoc. 2008 Nov;107(11):843-50. doi: 10.1016/S0929-6646(08)60200-4.
5
Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
J Nephrol. 2008 Jul-Aug;21(4):543-9.
6
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.
Nephrol Dial Transplant. 2008 Nov;23(11):3654-61. doi: 10.1093/ndt/gfn320. Epub 2008 Jun 27.
7
Correction of anemia with epoetin alfa in chronic kidney disease.
N Engl J Med. 2006 Nov 16;355(20):2085-98. doi: 10.1056/NEJMoa065485.
8
Darbepoetin alfa (Aranesp).
Proc (Bayl Univ Med Cent). 2002 Jul;15(3):332-5. doi: 10.1080/08998280.2002.11927861.
9
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials. 1996 Feb;17(1):1-12. doi: 10.1016/0197-2456(95)00134-4.
10
Multicenter trial of erythropoietin in patients on peritoneal dialysis.
J Am Soc Nephrol. 1995 Jan;5(7):1517-29. doi: 10.1681/ASN.V571517.
Zotero 插件